Sublingual fentanyl for refractory episodic acute dyspnea in patients with advanced chronic obstructive pulmonary disease (COPD): A real-world study-Reference-Cited by-同舟云学术

Sublingual fentanyl for refractory episodic acute dyspnea in patients with advanced chronic obstructive pulmonary disease (COPD): A real-world study

Published:2023-06-07 Issue:3 Volume:7 Page:144-147
ISSN:2474-5332
Container-title:Canadian Journal of Respiratory, Critical Care, and Sleep Medicine
language:en
Short-container-title:Canadian Journal of Respiratory, Critical Care, and Sleep Medicine

Author:

St-Pierre David¹,Gagnon Sébastien¹,Bergeron Kermelly Sophie¹,Marciniuk Jeffrey¹,Li Pei Zhi¹²,Ross Bryan¹²,Bourbeau Jean¹²^ORCID

Affiliation:

1. Montreal Chest Institute, McGill University Health Centre, Montreal, Quebec, Canada

2. Respiratory Epidemiology and Clinical Research Unit (RECRU), Center of Outcome and Research Evaluation, Research Institute McGill University Health Centre, Montreal, Quebec, Canada

Publisher

Informa UK Limited

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/24745332.2023.2224109

Reference17 articles.

1. Persistent disabling breathlessness in chronic obstructive pulmonary disease

2. Factors that influence disease-specific quality of life or health status in patients with COPD: a systematic review and meta-analysis of Pearson correlations

3. Understanding the impact of symptoms on the burden of COPD

4. “I Can Breathe Again!” Patients' Self-Management Strategies for Episodic Breathlessness in Advanced Disease, Derived From Qualitative Interviews

5. The impact of disease-specific fears on outcome measures of pulmonary rehabilitation in patients with COPD

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fentanyl;Reactions Weekly;2023-09-30